EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

The gut microbiota–brain axis in neurological disorders

Mingming You, Nan Chen, Yuanyuan Yang, Lingjun Cheng, Hongzhang He, Yanhua Cai, Yating Liu, Haiyue Liu, Guolin Hong

MedComm · 2024-08 · 5 (8)

DOI: 10.1002/mco2.656 ↗

At a glance

Übersichtsarbeit in MedComm, published online on 2024-07-20. Written by Mingming You and 8 co-authors. Institution: Xiamen Key Laboratory of Genetic Testing The Department of Laboratory Medicine The First Affiliated Hospital of Xiamen University, School of Medicine…. Cited 105 times so far (Crossref); 318 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Fujian Provincial Health Technology Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Previous studies have shown a bidirectional communication between human gut microbiota and the brain, known as the microbiota–gut–brain axis (MGBA). The MGBA influences the host's nervous system development, emotional regulation, and cognitive function through neurotransmitters, immune modulation, and metabolic pathways. Factors like diet, lifestyle, genetics, and environment shape the gut microbiota composition together. Most research have explored how gut microbiota regulates host physiology and its potential in preventing and treating neurological disorders. However, the individual heterogeneity of gut microbiota, strains playing a dominant role in neurological diseases, and the interactions of these microbial metabolites with the central/peripheral nervous systems still need exploration. This review summarizes the potential role of gut microbiota in driving neurodevelopmental disorders (autism spectrum disorder and attention deficit/hyperactivity disorder), neurodegenerative diseases (Alzheimer's and Parkinson's disease), and mood disorders (anxiety and depression) in recent years and discusses the current clinical and preclinical gut microbe‐based interventions, including dietary intervention, probiotics, prebiotics, and fecal microbiota transplantation. It also puts forward the current insufficient research on gut microbiota in neurological disorders and provides a framework for further research on neurological disorders.

Subjects

Author keywords

Alzheimer's diseaseParkinson's diseaseautismfecal microbiota transplantationgut microbiota–brain axisneurological disordersprobiotics

Authors and institutions

  • Xiamen Key Laboratory of Genetic Testing The Department of Laboratory Medicine The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University Xiamen China.
  • Master of Public Health School of Public Health Xiamen University Xiamen China.

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • Fujian Provincial Health Technology Project

Cite

APA

You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024). The gut microbiota–brain axis in neurological disorders. MedComm, 5(8). https://doi.org/10.1002/mco2.656

Vancouver

You M, Chen N, Yang Y, Cheng L, He H, Cai Y, et al. The gut microbiota–brain axis in neurological disorders. MedComm. 2024;5(8). doi:10.1002/mco2.656

BibTeX
@article{You2024,
  author = {You, Mingming and Chen, Nan and Yang, Yuanyuan and Cheng, Lingjun and He, Hongzhang and Cai, Yanhua and Liu, Yating and Liu, Haiyue and Hong, Guolin},
  title = {The gut microbiota–brain axis in neurological disorders},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {8},
  doi = {10.1002/mco2.656}
}
Start for free →